Profile data is unavailable for this security.
About the company
TransGenic Group Inc, formerly Trans Genic Inc is a Japan-based company mainly engaged in the drug discovery support business and the investment and consulting business. The Company operates through two business segments. The Drug Discovery Support Business segment provides seamless services that can handle all stages of drug discovery, from the initial stages of drug discovery, such as basic research and drug discovery research, to non-clinical and clinical trials. Its main services include contract production of genetically modified mice, contract production of antibodies and glycosylation analysis and synthesis. The Investment and Consulting Business segment promotes new businesses through mergers and acquisitions (M&A) and provides advice and support services related to business succession and business revitalization in a wide range of fields.
- Revenue in JPY (TTM)12.89bn
- Net income in JPY-769.96m
- Incorporated1998
- Employees241.00
- LocationTransGenic Group IncibbFUKUOKA Bldg.2-3-36, Tenjin, Chuo-kuFUKUOKA-SHI 810-0001JapanJPN
- Phone+81 922888470
- Fax+81 922888473
- Websitehttps://transgenic-group.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RAVIPA Ltd | 1.81bn | 250.23m | 1.06bn | 14.00 | -- | -- | 3.89 | 0.5877 | 126.38 | 126.38 | 915.05 | 213.88 | 2.07 | 4.23 | 15.98 | -- | 28.64 | -- | 48.57 | -- | 81.95 | -- | 13.81 | -- | 1.91 | 66.11 | 0.4788 | -- | 10.57 | -- | 153.87 | -- | -- | -- |
| Creema Ltd | 2.49bn | 38.98m | 1.66bn | 79.00 | 42.68 | 1.54 | 20.73 | 0.6688 | 5.79 | 5.79 | 369.34 | 160.70 | 0.7194 | -- | 4.65 | 31,507,770.00 | 1.13 | 1.06 | 3.01 | 2.87 | 79.64 | 85.35 | 1.57 | 1.54 | -- | 20.11 | 0.2955 | 0.00 | -0.078 | 10.56 | 30.17 | -- | -53.46 | -- |
| Yumemitsuketai Co Ltd | 308.06m | 134.97m | 2.15bn | 10.00 | 15.44 | 0.7843 | 22.72 | 6.99 | 13.34 | 13.34 | 30.45 | 262.66 | 0.0904 | 0.1767 | 16.96 | 30,805,900.00 | 3.96 | 3.16 | 4.62 | 4.03 | 59.60 | 50.38 | 43.81 | 22.90 | 0.114 | -- | 0.1997 | 0.00 | -53.58 | -13.45 | -35.50 | -- | -- | -- |
| P-Ban.Com Corp | 2.27bn | 132.66m | 2.55bn | 40.00 | 18.15 | 1.69 | 16.37 | 1.13 | 28.22 | 28.22 | 481.87 | 302.23 | 1.32 | 62.62 | 7.88 | 56,644,920.00 | 7.74 | 7.36 | 9.55 | 9.13 | 37.77 | 34.03 | 5.86 | 5.71 | 4.27 | 122.06 | 0.0166 | 34.11 | 8.18 | 0.439 | 20.64 | 0.1199 | -13.32 | 14.87 |
| Micreed Co Ltd | 7.42bn | 286.00m | 3.16bn | 28.00 | 11.04 | 1.97 | 9.12 | 0.4253 | 43.19 | 43.19 | 1,120.39 | 242.66 | 2.82 | 15.54 | 7.66 | 264,928,600.00 | 10.86 | 6.02 | 18.34 | 9.34 | 34.21 | 34.11 | 3.86 | 2.12 | 1.87 | -- | 0.00 | 20.53 | 14.15 | 10.72 | 16.22 | 19.70 | 35.89 | 46.52 |
| Tea Life Co Ltd | 11.22bn | 336.00m | 4.94bn | 144.00 | 14.67 | 0.7752 | 9.89 | 0.4401 | 78.74 | 78.74 | 2,628.11 | 1,490.04 | 1.27 | 7.55 | 12.05 | 77,881,940.00 | 3.82 | 6.01 | 4.45 | 7.19 | 36.44 | 37.85 | 3.00 | 4.09 | 3.36 | -- | 0.1231 | 40.06 | -11.53 | 1.69 | 12.23 | -3.18 | -46.63 | 5.92 |
| TransGenic Group Inc | 12.89bn | -769.96m | 5.03bn | 241.00 | -- | 0.9973 | -- | 0.3903 | -46.24 | -46.24 | 774.19 | 296.81 | 1.24 | 4.03 | 8.13 | 53,496,540.00 | -7.54 | 1.81 | -12.15 | 2.48 | 17.82 | 21.30 | -6.08 | 1.43 | 1.11 | -- | 0.3657 | 30.95 | -0.5987 | 3.32 | -26,774.20 | -- | -7.33 | -- |
| Kuradashi Co Ltd | 3.20bn | 40.69m | 5.16bn | 39.00 | 114.63 | 3.38 | 33.82 | 1.61 | 3.71 | 3.71 | 283.83 | 125.81 | 1.16 | 16.75 | 16.01 | 82,176,740.00 | 1.47 | -- | 2.09 | -- | 47.57 | -- | 1.27 | -- | 1.68 | 19.85 | 0.4997 | -- | 7.47 | -- | -348.89 | -- | -- | -- |
| J Frontier Co Ltd | 21.34bn | -111.68m | 7.12bn | 202.00 | -- | 5.07 | 11.65 | 0.3337 | -20.05 | -20.05 | 4,110.19 | 263.23 | 2.25 | 6.13 | 14.90 | 105,624,200.00 | -1.13 | -9.12 | -2.78 | -17.95 | 42.16 | 48.48 | -0.5043 | -3.85 | 0.7212 | -- | 0.707 | -- | 21.39 | 24.79 | 104.20 | -1.90 | 64.48 | -- |
| Crooz Inc | 11.71bn | -370.49m | 7.41bn | 712.00 | -- | 0.6155 | -- | 0.633 | -38.71 | -38.71 | 1,222.99 | 929.28 | 0.3776 | 14.06 | 4.97 | 16,444,680.00 | -1.20 | 1.75 | -1.48 | 2.27 | 50.52 | 36.58 | -3.18 | 2.47 | 1.88 | -12.70 | 0.686 | 0.00 | -0.5516 | -16.03 | -152.61 | -- | -6.78 | -- |
| Hamee Corp | 23.45bn | 912.13m | 7.85bn | 489.00 | 8.43 | 0.6929 | 4.36 | 0.3349 | 57.09 | 57.09 | 1,467.97 | 694.16 | 1.29 | 2.17 | 8.60 | 47,955,960.00 | 5.01 | 11.41 | 7.90 | 15.53 | 59.41 | 60.91 | 3.89 | 8.27 | 1.38 | 11.13 | 0.3168 | 23.96 | 30.00 | 15.12 | 13.94 | 3.63 | 3.82 | 26.30 |
| Felissimo Corp | 29.52bn | 577.00m | 8.26bn | 419.00 | 10.69 | 0.3165 | 5.71 | 0.28 | 81.01 | 81.01 | 4,144.56 | 2,736.08 | 1.02 | 2.79 | 9.35 | 70,453,460.00 | 1.99 | 1.83 | 2.63 | 2.58 | 54.47 | 53.59 | 1.95 | 1.83 | 1.94 | -- | 0.00 | 18.35 | -0.5337 | 0.5819 | 115.85 | -17.92 | -11.50 | 24.57 |
| Holder | Shares | % Held |
|---|---|---|
| Yuki Management & Research Co. Ltd.as of 31 Jan 2022 | 0.00 | 0.00% |
